Boiron buys Spain's Hivital Labs in first major deal in 20 years
What's the deal? Les Laboratoires BoironDealroom has a profile for this one. Try Dealroom → has acquired 100% of Hivital Labs, a Barcelona-area company that sells food supplements online. Announced November 16, 2026, it is the French group's first significant acquisition in more than 20 years. The price was not disclosed.
What each side brings: Founded in 2018 by Ferran Forcada, Hivital Labs sells about 70 products — covering sleep, stress, immunity, digestion and joints — mainly online in Spain, Germany, Italy and France. Boiron, known for its homeopathic medicines, contributes its international network and industrial and logistics capabilities.
What changes? Not much for Hivital Labs, which keeps its brand, team and operating autonomy. Forcada stays on as managing director, reporting to Boiron chief executive officer Pascal Houdayer.
Why now? The deal advances a strategy Boiron launched in early 2025 to expand in supplements and e-commerce — channels distinct from its traditional business. Houdayer said he wants to open "a new phase of its development, in respect of its identity, its agility and its entrepreneurial spirit" (translated from French).
Why it matters: Boiron's first-half 2026 revenue was broadly stable, but operating income fell by €8.2 million, making growth beyond homeopathy more pressing. Hivital Labs generated more than €10 million in 2025. Boiron's board approved the purchase unanimously and is financing it from available cash.
What could go wrong? With the price undisclosed, the deal's financial impact — and whether the new online channel can scale profitably — remains unclear.
The signal: A homeopathy specialist is betting on direct-to-consumer supplements to offset pressure on its core business, buying the digital expertise it lacks rather than building it.
Read more: leprogres.fr
Image credit: "Vitamin Packaging" by colindunn, licensed under CC BY 2.0